Airbus and Dassault Aviation have reached a tentative deal on the Future Combat Air System (FCAS) fighter project, paving the way for political level talks to resume among the project’s three government backers France, Germany, and Spain
The FCAS program has been hounded by political differences and corporate disagreements that led to weeks of deadlock.
The joint proposal from European defense group Airbus and Dassault still faces outstanding issues, including intellectual property matters,
The FCAS is set to replace the German-Spanish Eurofighter and French Dassault Rafale with a combination of manned and unmanned aircraft from 2040.
According to Dassault CEO Eric Trappier, his company had accepted that Airbus will receive a larger overall share of FCAS work but is ready with an alternative plan if the talks failed.
The industrial partners in the FCAS program are Germany's Airbus, France’s Dassault, and Spain's Indra.
Separate engine supply negotiations have been taking place with France's Safran, Germany's MTU Aero, and ITP, a Spanish subsidiary of Rolls Royce.
The FCAS is also up against the rival BAE Systems-led Tempest fighter project of the UK, Sweden, and Italy.


Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Anta Sports Expands Global Footprint With Strategic Puma Stake
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision
Washington Post Publisher Will Lewis Steps Down After Layoffs
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal 



